Korro Bio, Inc. (KRRO)

Korro Bio Statistics

Total Valuation

Korro Bio has a market cap or net worth of $165.81 million. The enterprise value is $51.56 million.

Market Cap	165.81M
Enterprise Value	51.56M

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025, after market close.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Korro Bio has 9.39 million shares outstanding. The number of shares has increased by 483.30% in one year.

Current Share Class	9.39M
Shares Outstanding	9.39M
Shares Change (YoY)	+483.30%
Shares Change (QoQ)	+0.69%
Owned by Insiders (%)	6.41%
Owned by Institutions (%)	60.81%
Float	4.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	71.06
Forward PS	n/a
PB Ratio	1.06
P/TBV Ratio	1.06
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	22.70
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.79, with a Debt / Equity ratio of 0.28.

Current Ratio	8.79
Quick Ratio	8.54
Debt / Equity	0.28
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -50.61% and return on invested capital (ROIC) is -28.14%.

Return on Equity (ROE)	-50.61%
Return on Assets (ROA)	-25.65%
Return on Invested Capital (ROIC)	-28.14%
Return on Capital Employed (ROCE)	-43.50%
Revenue Per Employee	$21,837
Profits Per Employee	-$803,663
Employee Count	104
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

In the past 12 months, Korro Bio has paid $141,000 in taxes.

Income Tax	141,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -71.96% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-71.96%
50-Day Moving Average	20.51
200-Day Moving Average	39.02
Relative Strength Index (RSI)	53.29
Average Volume (20 Days)	116,147

Short Selling Information

The latest short interest is 884,077, so 9.42% of the outstanding shares have been sold short.

Short Interest	884,077
Short Previous Month	826,301
Short % of Shares Out	9.42%
Short % of Float	17.99%
Short Ratio (days to cover)	8.32

Income Statement

In the last 12 months, Korro Bio had revenue of $2.27 million and -$83.58 million in losses. Loss per share was -$9.37.

Revenue	2.27M
Gross Profit	2.27M
Operating Income	-91.91M
Pretax Income	-81.17M
Net Income	-83.58M
EBITDA	-88.35M
EBIT	-91.91M
Loss Per Share	-$9.37

Balance Sheet

The company has $126.10 million in cash and $44.77 million in debt, giving a net cash position of $118.29 million or $12.60 per share.

Cash & Cash Equivalents	126.10M
Total Debt	44.77M
Net Cash	118.29M
Net Cash Per Share	$12.60
Equity (Book Value)	160.42M
Book Value Per Share	17.11
Working Capital	116.57M

Cash Flow

In the last 12 months, operating cash flow was -$60.07 million and capital expenditures -$17.90 million, giving a free cash flow of -$77.98 million.

Operating Cash Flow	-60.07M
Capital Expenditures	-17.90M
Free Cash Flow	-77.98M
FCF Per Share	-$8.31

Margins

Gross Margin	100.00%
Operating Margin	-4,047.12%
Pretax Margin	-3,674.15%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Korro Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-483.30%
Shareholder Yield	-483.30%
Earnings Yield	-49.21%
FCF Yield	-45.91%

Analyst Forecast

The average price target for Korro Bio is $106.33, which is 502.10% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$106.33
Price Target Difference	502.10%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	123.67%
EPS Growth Forecast (5Y)	7.49%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Korro Bio has an Altman Z-Score of 1.73 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.73
Piotroski F-Score	1